genedrive plc has proposed a Share Capital Reorganization to enhance financing options due to current market conditions. The Company reported a doubling of total income for FY25 and anticipates significant developments in the healthcare sector. With cash balances of circa £700,000 and a future cash runway until mid-October 2025, the Board aims to secure additional working capital through the issuance of new shares. The Reorganization involves subdividing Existing Ordinary Shares to facilitate future equity financing. Shareholder approval is sought at the General Meeting scheduled for 15 September 2025. The Board recommends voting in favor of Resolutions to support the Company's growth strategy. Investors can participate in the upcoming General Meeting to learn more about the proposed Reorganization and financing plans. The Company is focused on addressing global healthcare challenges and expanding its market presence. For specific details and clarifications, investors are encouraged to reach out to genedrive plc directly through the provided contact information. Your engagement and questions are valued as we move forward with these strategic initiatives.